Stay updated on TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedNo significant changes detected on the Study Details page (NCT03727802); core information such as objectives, eligibility criteria, and contact details remains unchanged.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check36 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference5%

- Check43 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety and counterfeit/substandard drugs) have been removed. Overall, this is a minor, metadata-level update with no significant changes to core content or time-sensitive information.SummaryDifference0.8%

- Check57 days agoChange DetectedRevision updated to v3.0.2; removed 'Back to Top'.SummaryDifference0.3%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check72 days agoChange DetectedThe web page has added significant information regarding the facility name, location, and various publications related to drug safety and interstitial lung disease, while removing specific geographic details and certain medical terms.SummaryDifference8%

Stay in the know with updates to TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.